Table 4.
Functional outcome scores and range of motions at twelve months follow-up in DePuy Delta Xtend and Arthrex Universe Reverse prostheses independent of subscapularis refixation
| Depuy Delta Xtend (n = 19) | Arthrex Universe Reverse (n = 22) | p value | |
|---|---|---|---|
| CS | 71 (13–87) | 71 (40–90) | 0.875 |
| aCS | 80.9 (13.2–96.8) | 80.8 (42.9–91.1) | 0.875 |
| ASES | 90 (8–98) | 91 (27–98) | 0.733 |
| Pain | 0 (0–8) | 0 (0–5.3) | 0.887 |
| Strength abductiona | 7 (3–25) | 4 (2–18) | 0.044 |
| Strength flexiona | 7 (2–19) | 6 (2–20) | 0.322 |
| FF | 138 (55–158) | 140 (100–170) | 0.3 |
| ABD | 125 (40–148) | 127.5 (70–152) | 0.276 |
| IRO | 39 (25–50) | 38 (20–60) | 0.545 |
| IROa | 8 (0–10) | 6 (0–10) | 0.873 |
| ARO | 14 (0–40) | 22.5 (0–38) | 0.338 |
| AROa | 10 (0–10) | 10 (6–10) | 0.012 |
Median and ranges for the single values are provided, p < 0.05 was considered statistically significant
(a)CS (adjusted) Constant–Murley Shoulder Score (points), ASES American Shoulder and Elbow Surgeons Score (points), pain on numeric rating scale (0–10 points), FF forward flexion, ABD abduction, IRO internal rotation, ARO external rotation; values are given in degree
aStrength measured in 90° abduction and forward flexion, internal rotation (IRO) and external rotation (ARO) measured in CS, values are given as reached points in CS
Significant differences between groups are highlighted in bold